138 related articles for article (PubMed ID: 22844371)
1. Case report of concurrent primary malignancies of the breast and nasopharynx.
Pan X; Zhu X; Li QQ
Oncol Lett; 2012 Aug; 4(2):285-288. PubMed ID: 22844371
[TBL] [Abstract][Full Text] [Related]
2. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.
Chu EA; Wu JM; Tunkel DE; Ishman SL
Medscape J Med; 2008 Jul; 10(7):165. PubMed ID: 18769688
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.
Andersson-Anvret M; Forsby N; Klein G; Henle W
Int J Cancer; 1977 Oct; 20(4):486-94. PubMed ID: 199543
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus infection is equally distributed across the invasive ductal and invasive lobular forms of breast cancer.
Ballard AJ
Pathol Res Pract; 2015 Dec; 211(12):1003-5. PubMed ID: 26481274
[TBL] [Abstract][Full Text] [Related]
7. Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?
Ribeiro-Silva A; Ramalho LN; Garcia SB; Zucoloto S
Braz J Med Biol Res; 2004 Jan; 37(1):89-95. PubMed ID: 14689049
[TBL] [Abstract][Full Text] [Related]
8. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection.
Guo C; Pan ZG; Li DJ; Yun JP; Zheng MZ; Hu ZY; Cheng LZ; Zeng YX
J Transl Med; 2006 May; 4():23. PubMed ID: 16729897
[TBL] [Abstract][Full Text] [Related]
9. No significant association of Epstein-Barr virus infection with invasive breast carcinoma.
Chu PG; Chang KL; Chen YY; Chen WG; Weiss LM
Am J Pathol; 2001 Aug; 159(2):571-8. PubMed ID: 11485915
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Carcinoma With Bilateral Breast Metastasis: A Report of an Elusive Case.
Soni SV; Malhotra V; Sharma R; Singh M; Dixit R; Mallya V
Cureus; 2022 Jul; 14(7):e27497. PubMed ID: 36060330
[TBL] [Abstract][Full Text] [Related]
12. Clonal dynamics of tumor-infiltrating T-cell receptor beta-chain repertoires in the peripheral blood in response to concurrent chemoradiotherapy for Epstein-Barr virus-associated nasopharyngeal carcinoma.
Chung YL; Wu ML
Oncoimmunology; 2021; 10(1):1968172. PubMed ID: 34513316
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.
Adham M; Greijer AE; Verkuijlen SA; Juwana H; Fleig S; Rachmadi L; Malik O; Kurniawan AN; Roezin A; Gondhowiardjo S; Atmakusumah D; Stevens SJ; Hermani B; Tan IB; Middeldorp JM
Clin Cancer Res; 2013 Apr; 19(8):2175-86. PubMed ID: 23493345
[TBL] [Abstract][Full Text] [Related]
14. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
[TBL] [Abstract][Full Text] [Related]
15. EBV-positive large-cell and small-cell neuroendocrine carcinoma of the nasopharynx: A case report and review of the literature.
Su Z; Yan HW; Zou GR
Oncol Lett; 2022 Dec; 24(6):464. PubMed ID: 36406180
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay.
Li Y; Wang K; Yin SK; Zheng HL; Min DL
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050964
[TBL] [Abstract][Full Text] [Related]
17. [Identification of a nasopharyngeal carcinoma using Epstein-Barr virus diagnosis].
Hamadi I; Steinhart H; Pahl S; Constantinidis J; Iro H
HNO; 2000 Apr; 48(4):314-7. PubMed ID: 10810679
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
[TBL] [Abstract][Full Text] [Related]
19. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
